Newsroom

Blog

It’s a Great Clinical Trial Assay

While there are many great tools and technologies available to support drug development, the number of platforms used for CDx development remains very limited.

Read More

Is It Validated?

NeoGenomics has a menu of >600 assays across many different technologies and approaches.

Read More

Liquid Biopsy Testing for PIK3CA Mutation

For years, researchers have looked into liquid biopsy as a potentially useful tool to help Health Care Providers assess a patient’s response to treatment, monitor cancer recurrence and even detect

Read More

A spotlight on CDx development

NeoGenomics will share several posts focusing on CDx development.

Read More

Being Comprehensive in Hematologic Malignancies

The need for comprehensive testing seems obvious in the context of working up most cases of hematologic malignancies.

Read More

Improving Diagnosis of Barrett’s Esophagus

Esophageal cancer, while relatively uncommon, has risen dramatically over the past several decades.

Read More
Written By:
DennisPOMalley.jpg
Dennis P. O’Malley

Expert approaches to resolving challenging areas in diagnostic pathology

The past decade has seen considerable diagnostic advances distinguishing classic Hodgkin lymphoma (CHL) from other lymphoma mimics.

Read More
Written By:
DennisPOMalley.jpg
Dennis P. O’Malley

MultiOmyx 101: An Introduction to Multiplexing Technology

Cancer claims more than half a million lives each year in the United States alone.

Read More
Written By:
AnnaJunckerJensen.jpg
Anna Juncker-Jensen

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients